34
Views
5
CrossRef citations to date
0
Altmetric
Miscellaneous

Cushing’s syndrome: drug targets and therapeutic options

, &
Pages 1537-1546 | Published online: 25 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Edgar G Durán-Pérez, Oscar T Moreno-Loza, German Carrasco-Tobón & Antonio Segovia-Palomo. (2012) Optimal management of Cushing syndrome. Research and Reports in Endocrine Disorders 2, pages 19-30.
Read now

Articles from other publishers (4)

V.A. Castillo, N.V. Gómez, J.C. Lalia, M.F. Cabrera Blatter & J.D. García. (2008) Cushing’s disease in dogs: Cabergoline treatment. Research in Veterinary Science 85:1, pages 26-34.
Crossref
Xiaojun Han, Rita Civiello, Sokhom S. Pin, Kevin Burris, Lynn A. Balanda, Jay Knipe, Shelly Ren, Tracey Fiedler, Kaitlin E. Browman, Robert Macci, Matthew T. Taber, Jie Zhang & Gene M. Dubowchik. (2007) An orally active corticotropin releasing factor 1 receptor antagonist from 8-aryl-1,3a,7,8-tetraaza-cyclopenta[a]indenes. Bioorganic & Medicinal Chemistry Letters 17:7, pages 2026-2030.
Crossref
Xiaojun Han, Sokhom S. Pin, Kevin Burris, Lawrence K. Fung, Stella Huang, Matthew T. Taber, Jie Zhang & Gene M. Dubowchik. (2005) Synthesis and structure–activity relationship of imidazo[1,2-a]benzimidazoles as corticotropin-releasing factor 1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 15:18, pages 4029-4032.
Crossref
Cheryl A. Pickett. (2005) Update on the medical management of pituitary adenomas. Current Neurology and Neuroscience Reports 5:3, pages 178-185.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.